Therefore, our findings identified IL-10 as an additional mediator of anti-proliferative capabilities of SLE/ASCs, adding new evidence of this cytokine contribution to immunoregulatory mechanisms known to be mediated by regulatory lymphocytes (Treg, Breg) (Geginat et al., 2019). The gene discussed is IL10; the disease is systemic lupus erythematosus.